Navigating Therapeutic drug monitoring of Isavuconazole in Invasive Mold Infection on Extracorporeal membrane oxygenation - A Case Report. (PubMed, Innov Pharm) - Jun 9, 2026 - "The patient was switched to voriconazole and liposomal amphotericin B. The patient achieved clinical improvement and switched back to isavuconazole to complete a 12-week course after ECMO decannulation occurred. This case highlights the importance of isavuconazole TDM, especially during ECMO, and consideration of alternative agents if necessary."
Journal • Infectious Disease • Pulmonary Disease • Respiratory Diseases
|
|
Alexandria Rydz; Blain Thayer; Jenna Fleming; Justin Sorenson; Michael Arnold; Taylor D Steuber; Taylor Nelson
|